Eikon Therapeutics (EIKN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $7.42, -1.59% vs the prior close of $7.54.
- Volume 482.77K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
EIKN dips 1.6% to $7.42. Closed at $7.42, -1.59% vs the prior close of $7.54. Day range $7.18–$7.76, opened at $7.73.
EIKN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — EIKN dips 1.6% to $7.42
- Closed at $7.42, -1.59% vs the prior close of $7.54. Day range $7.18–$7.76, opened at $7.73.
- Volume was 482.77K shares, 0.8x its 50-day average of 582.73K.
- Price is -20.9% vs its 50-day average ($9.38).
- 52-week range $6.45–$17.40; today's close sits at 9% of that range, 57.4% below the 52-week high.
Oct 15, 2026 — EIKN jumps 7.6% to $7.54
- Closed at $7.54, +7.56% vs the prior close of $7.01. Day range $7.01–$7.69, opened at $7.01.
- Volume was 654.40K shares, 1.1x its 50-day average of 575.18K.
- Price is -19.9% vs its 50-day average ($9.41).
- 52-week range $6.45–$17.40; today's close sits at 10% of that range, 56.7% below the 52-week high.
Oct 14, 2026 — EIKN jumps 4.3% to $7.01
- Closed at $7.01, +4.32% vs the prior close of $6.72. Day range $6.45–$7.07, opened at $6.69.
- Volume was 595.50K shares, 1.0x its 50-day average of 571.19K.
- Price is -25.8% vs its 50-day average ($9.45).
- 52-week range $6.45–$17.40; today's close sits at 5% of that range, 59.7% below the 52-week high.
Oct 13, 2026 — EIKN slides 7.4% to $6.72, a 6-month low, 4 down days in a row
- Closed at $6.72, -7.44% vs the prior close of $7.26. Day range $6.71–$7.30, opened at $7.19.
- Volume was 406.70K shares, 0.7x its 50-day average of 568.19K.
- Price is -29.3% vs its 50-day average ($9.50).
- 52-week range $6.71–$17.40; today's close sits at 0% of that range, 61.4% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — EIKN dips 2.8% to $7.26, a 6-month low, 3 down days in a row
- Closed at $7.26, -2.81% vs the prior close of $7.47. Day range $7.16–$7.60, opened at $7.45.
- Volume was 236.20K shares, 0.4x its 50-day average of 568.17K — lighter than usual.
- Price is -24.0% vs its 50-day average ($9.55).
- 52-week range $7.02–$17.40; today's close sits at 2% of that range, 58.3% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — EIKN dips 0.4% to $7.47
- Closed at $7.47, -0.40% vs the prior close of $7.50. Day range $7.25–$7.82, opened at $7.48.
- Volume was 288.70K shares, 0.5x its 50-day average of 567.76K — lighter than usual.
- Price is -22.1% vs its 50-day average ($9.59).
- 52-week range $7.02–$17.40; today's close sits at 4% of that range, 57.1% below the 52-week high.
Oct 8, 2026 — EIKN dips 0.5% to $7.50
- Closed at $7.50, -0.53% vs the prior close of $7.54. Day range $7.19–$7.74, opened at $7.48.
- Volume was 847.10K shares, 1.5x its 50-day average of 555.76K.
- Price is -22.1% vs its 50-day average ($9.63).
- 52-week range $7.02–$17.40; today's close sits at 5% of that range, 56.9% below the 52-week high.
Oct 7, 2026 — EIKN rises 0.4% to $7.54
- Closed at $7.54, +0.40% vs the prior close of $7.51. Day range $7.11–$7.63, opened at $7.32.
- Volume was 920.20K shares, 1.7x its 50-day average of 541.69K.
- Price is -22.0% vs its 50-day average ($9.66).
- 52-week range $7.02–$17.40; today's close sits at 5% of that range, 56.7% below the 52-week high.
Oct 6, 2026 — EIKN dips 0.4% to $7.51
- Closed at $7.51, -0.40% vs the prior close of $7.54. Day range $7.43–$7.84, opened at $7.67.
- Volume was 610.80K shares, 1.1x its 50-day average of 535.27K.
- Price is -22.6% vs its 50-day average ($9.70).
- 52-week range $7.02–$17.40; today's close sits at 5% of that range, 56.8% below the 52-week high.
Oct 5, 2026 — EIKN rises 2.9% to $7.54
- Closed at $7.54, +2.86% vs the prior close of $7.33. Day range $7.02–$7.66, opened at $7.42.
- Volume was 485.30K shares, 0.9x its 50-day average of 530.54K.
- Price is -22.7% vs its 50-day average ($9.75).
- 52-week range $7.02–$17.40; today's close sits at 5% of that range, 56.7% below the 52-week high.
Oct 2, 2026 — EIKN dips 1.1% to $7.33, a 6-month low
- Closed at $7.33, -1.08% vs the prior close of $7.41. Day range $7.07–$7.55, opened at $7.55.
- Volume was 420.40K shares, 0.8x its 50-day average of 526.98K.
- Price is -25.0% vs its 50-day average ($9.78).
- 52-week range $7.07–$17.40; today's close sits at 3% of that range, 57.9% below the 52-week high.
EIKN latest news & SEC filings
Every SEC filing by or about EIKN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 2, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kutzkey Tim bought 89,200 shares at $11.56 (≈$1.03M) on Sep 3, 2026
- Kutzkey Tim bought 89,200 shares at $11.56 (≈$1.03M) on Sep 3, 2026
- Column Group Iv Gp, Lp bought 89,200 shares at $11.56 (≈$1.03M) on Sep 3, 2026
- Column Group Iv Gp, Lp bought 89,200 shares at $11.56 (≈$1.03M) on Sep 3, 2026
- Column Group Opportunity Iii Gp, Lp bought 89,200 shares at $11.56 (≈$1.03M) on Sep 3, 2026
- Column Group Opportunity Iii Gp, Lp bought 89,200 shares at $11.56 (≈$1.03M) on Sep 3, 2026
- …plus 19 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$88.41M (prior year -$105.21M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$1.63 (prior year -$36.94) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 6, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade EIKN
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Mar 30, 2026. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.90% (largest 9.5%).
- Liquidity: about 531.86K shares (≈$3.95M) trade per day on average.
- 52-week position: $7.42 vs a range of $6.45–$17.40 (9% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Tim Kutzkey bought 89,200 shares on Sep 3, 2026.
- Latest filings: 8-K Aug 14, 2026; 10-Q Aug 13, 2026; 8-K Aug 13, 2026.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
EIKN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 7.73 | 7.76 | 7.18 | 7.42 | 482.77K |
| Oct 15, 2026 | 7.01 | 7.69 | 7.01 | 7.54 | 654.40K |
| Oct 14, 2026 | 6.69 | 7.07 | 6.45 | 7.01 | 595.50K |
| Oct 13, 2026 | 7.19 | 7.30 | 6.71 | 6.72 | 406.70K |
| Oct 12, 2026 | 7.45 | 7.60 | 7.16 | 7.26 | 236.20K |
| Oct 9, 2026 | 7.48 | 7.82 | 7.25 | 7.47 | 288.70K |
| Oct 8, 2026 | 7.48 | 7.74 | 7.19 | 7.50 | 847.10K |
| Oct 7, 2026 | 7.32 | 7.63 | 7.11 | 7.54 | 920.20K |
| Oct 6, 2026 | 7.67 | 7.84 | 7.43 | 7.51 | 610.80K |
| Oct 5, 2026 | 7.42 | 7.66 | 7.02 | 7.54 | 485.30K |
| Oct 2, 2026 | 7.55 | 7.55 | 7.07 | 7.33 | 420.40K |
| Oct 1, 2026 | 8.00 | 8.09 | 7.40 | 7.41 | 624.60K |
| Sep 30, 2026 | 7.95 | 8.16 | 7.71 | 8.04 | 585.80K |
| Sep 29, 2026 | 7.88 | 8.10 | 7.80 | 7.91 | 334.80K |
| Sep 28, 2026 | 7.81 | 8.00 | 7.55 | 7.91 | 435.00K |
| Sep 25, 2026 | 8.45 | 8.47 | 7.87 | 7.92 | 377.10K |
| Sep 24, 2026 | 8.14 | 8.40 | 7.72 | 8.29 | 710.00K |
| Sep 23, 2026 | 8.94 | 8.94 | 7.96 | 8.13 | 727.30K |
| Sep 22, 2026 | 8.97 | 9.33 | 8.75 | 8.98 | 430.70K |
| Sep 21, 2026 | 9.06 | 9.16 | 8.65 | 8.83 | 463.90K |
About Eikon Therapeutics
Eikon Therapeutics (EIKN) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in MILLBRAE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1861123.
EIKN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Leon Chen | Director | Feb 4, 2026 |
| Kenneth C Frazier | Director | Mar 4, 2026 |
| Ma. Fatima Francisco | Director | Jun 15, 2026 |
| Robert Luther Huffines | Director | Mar 4, 2026 |
| David W Meline | Director | Feb 4, 2026 |
| Roger M Perlmutter | See remarks | Mar 4, 2026 |
| Josh Wolfe | Director | Feb 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Roy D. Baynes | Chief Medical Officer | Mar 4, 2026 |
| Alfred Lloyd Jr. Bowie | Chief Financial Officer | Mar 4, 2026 |
| Michael A Klobuchar | Chief Operating Officer | Mar 4, 2026 |
| Roger M Perlmutter | See remarks | Mar 4, 2026 |
| Benjamin Bruno Thorner | See Remarks | Mar 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Tim Kutzkey | Buy | 89,200 | $11.56 |
| Sep 3, 2026 | Tim Kutzkey | Buy | 89,200 | $11.56 |
| Sep 3, 2026 | Group Iv Gp, Lp Column | Buy | 89,200 | $11.56 |
| Sep 3, 2026 | Group Iv Gp, Lp Column | Buy | 89,200 | $11.56 |
| Sep 3, 2026 | Group Opportunity Iii Gp, Lp Column | Buy | 89,200 | $11.56 |
| Sep 3, 2026 | Group Opportunity Iii Gp, Lp Column | Buy | 89,200 | $11.56 |
| Sep 3, 2026 | Opportunity Iii Gp, Llc Tcg | Buy | 89,200 | $11.56 |
| Sep 3, 2026 | Opportunity Iii Gp, Llc Tcg | Buy | 89,200 | $11.56 |
| Sep 3, 2026 | Group Iv-A, Lp Column | Buy | 89,200 | $11.56 |
| Sep 3, 2026 | Group Iv-A, Lp Column | Buy | 89,200 | $11.56 |
| Sep 3, 2026 | Group Iv, Lp Column | Buy | 89,200 | $11.56 |
| Sep 3, 2026 | Group Iv, Lp Column | Buy | 89,200 | $11.56 |
| Sep 3, 2026 | Group Opportunity Iii, Lp Column | Buy | 89,200 | $11.56 |
| Sep 3, 2026 | Group Opportunity Iii, Lp Column | Buy | 89,200 | $11.56 |
| Sep 3, 2026 | Peter Svennilson | Buy | 89,200 | $11.56 |
EIKN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $779.57M, total liabilities $313.07M, cash $142.61M (as of Jun 30, 2026).
EIKN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $10.33 |
| May 11, 2026 | 8-K Item 2.02 (results) | $9.95 |
| Mar 30, 2026 | 8-K Item 2.02 (results) | $9.68 |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on EIKN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.